Parkman Healthcare Partners’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-217,978
| Closed | -$344K | – | 103 |
|
|
2025
Q1 | $344K | Buy |
217,978
+65,005
| +42% | +$103K | 0.04% | 89 |
|
|
2024
Q4 | $512K | Sell |
152,973
-50,000
| -25% | -$168K | 0.07% | 88 |
|
|
2024
Q3 | $382K | Sell |
202,973
-142,233
| -41% | -$267K | 0.05% | 91 |
|
|
2024
Q2 | $680K | Sell |
345,206
-351,264
| -50% | -$692K | 0.09% | 83 |
|
|
2024
Q1 | $2.14M | Hold |
696,470
| – | – | 0.26% | 83 |
|
|
2023
Q4 | $1.62M | Buy |
+696,470
| New | +$1.62M | 0.23% | 72 |
|
|
2020
Q2 | – | Sell |
-5,644
| Closed | -$1.09M | – | 84 |
|
|
2020
Q1 | $1.09M | Buy |
+5,644
| New | +$1.09M | 0.5% | 52 |
|